Featured Research

from universities, journals, and other organizations

Allergies Increase Risk For Corneal Transplant Rejection, UT Southwestern Study Shows

Date:
May 20, 2005
Source:
UT Southwestern Medical Center
Summary:
Corneal transplant patients who suffer from eye allergies are at a significantly higher risk of transplant failure than those without allergies, UT Southwestern Medical Center researchers have shown.

Dr. Jerry Niederkorn, professor of ophthalmology, and other UT Southwestern researchers like research assistant Christina Stevens have shown that corneal transplant patients who suffer from eye allergies are at a significantly higher risk of transplant failure than those without allergies.
Credit: Image courtesy of UT Southwestern Medical Center

DALLAS (May 20, 2005) -- Corneal transplant patients who suffer from eye allergies are at a significantly higher risk of transplant failure than those without allergies, UT Southwestern Medical Center researchers have shown.

"We found that the immune system's response to corneal transplants was profoundly elevated in mice with allergic eye disease, resulting in the rejection of 100 percent of the corneal grafts. This was in sharp contrast to the 50 percent rejection rate that occurred in the mice without allergic eye disease," said Dr. Jerry Niederkorn, professor of ophthalmology.

Results of the study, scheduled to go online today, will appear in the June issue of the Journal of Immunology.

"The study provides insights that might explain clinical observations that patients with eye allergies have a significantly higher risk for rejecting corneal transplants than patients without eye allergies," said Dr. Niederkorn, senior author of the study. "The allergist and ophthalmologist need to work as partners in managing the allergic patient who is destined to receive a corneal transplant."

The immune system is programmed to react to organ transplants by producing a specific pattern of proteins that promote a destructive immune response, which culminates in graft rejection. The immune system responds in a markedly different manner when confronted with allergens, producing an opposing pattern of proteins.

Proteins associated with allergic responses are known to inhibit immune cells and thus, were previously believed to prevent graft rejection.

"In this study, however, the opposite was found to be true," Dr. Niederkorn said. "The presence of eye allergies altered the immune system's response to the corneal transplants in a manner that resembled a severe allergic response and culminated in a dramatic increase in corneal graft rejection."

Researchers applied ragweed pollen for several days to the right eyes of mice awaiting corneal transplantation, inducing allergic eye disease similar to that found in patients with ocular allergies. Another group of mice served as a control group, and corneal grafts were rejected in 50 percent of them; however, all of the grafts were rejected in mice with ocular ragweed allergy.

The allergic mice also had a rejection rate twice as fast as the control group. Researchers then performed additional experiments to determine if the increased graft rejection was simply due to the inflammation and irritation in the eye produced by the allergic response to ragweed pollen. In these experiments, ragweed pollen was applied to the right eye of the mice but the cornea was transplanted to the left eye, which was free of local allergic responses. All of the corneal transplants were still rejected.

"These findings demonstrate that the presence of eye allergies can have a profound effect on the immune system that reaches beyond the local site of an allergic response, in this case, the eye," Dr. Niederkorn said. "The results offer hope for improving the success of corneal transplants in patients with allergic eye diseases."

UT Southwestern ophthalmology researchers involved in the study included Dr. Clay Beauregard, postdoctoral research fellow and lead author; Elizabeth Mayhew, research scientist; and Christina Stevens, research assistant.

The study was funded by the National Institutes of Health and Research to Prevent Blindness.



Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

UT Southwestern Medical Center. "Allergies Increase Risk For Corneal Transplant Rejection, UT Southwestern Study Shows." ScienceDaily. ScienceDaily, 20 May 2005. <www.sciencedaily.com/releases/2005/05/050520172338.htm>.
UT Southwestern Medical Center. (2005, May 20). Allergies Increase Risk For Corneal Transplant Rejection, UT Southwestern Study Shows. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2005/05/050520172338.htm
UT Southwestern Medical Center. "Allergies Increase Risk For Corneal Transplant Rejection, UT Southwestern Study Shows." ScienceDaily. www.sciencedaily.com/releases/2005/05/050520172338.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins